Novartis completed about $25 billion of transactions in its product portfolios, including the sale of two units to British-based GlaxoSmithKline. The WSJ explains why the Swiss company is doing these deals now and what this means for the pharmaceutical industry.
WSJ discusses the Ackman/Valeant deal for Allergan. ...
A doctor created goggles that help surgeons detect cancer cells injected with dye. ...
Older adults who take aspirin and ibuprofen may face added heart risk.
There's heightened concern after the confirmation of more cases of the deadly Middle East Respiratory Syndrome, or MERS, in Saudi Arabia and Jordan over the weekend.
Report details the dangers of testing Ebola, which has already claimed the lives of 14 healthcare workers.
Women are at higher risk for some eye diseases than men and the majority aren't aware of this.
Report details the public health risks of skipping childhood vaccines.
Report details when it's OK to use a drug that has expired and when it's not.
One person dies every 36 minutes from an opioid overdose from painkillers. A recently approved drug aims to reverse that trend.
A new study in the American Journal of Hypertension says that too little salt can be equally as dangerous as too much.
Runaway demand for a life-saving hepatitis C treatment that costs $1,000 a day could send insurers' earnings per share down by double-digit percentages this year.
Schuyler Ebersol turned to writing to help overcome a strange disease.
Nearly 20% of breast cancers diagnosed by mammogram would never cause problems if left alone, according to a new report.
Health officials are scrambling to contain an outbreak of Ebola that has spread to Conakry, Guinea.
Doctors say the main cause is more parents choosing not to have their children vaccinated.
Retired Northwest Airlines pilot David Funk discusses the systems in place to ensure pilots are stable enough to fly.
Antibiotics help treat UTIs but a new drug may get rid of hard-to-reach bacteria causing infection.